Delivery Order SPE2DB24D3013-SPE2DB25FFMGV

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $2,848.01 and a period of performance through May 1, 2025. It is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a medication, with a ceiling value of $1,305.85 and a completion date of January 29, 2025. The contract is a firm fixed-price, indefinite delivery type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $2,284.22 and an ultimate completion date of February 21, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The order is valued at $6,104.90 and has a delivery deadline of October 15, 2024. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,789.97 and a completion date of May 22, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,917.80 and an ultimate completion date of May 20, 2025. The contract is not set-aside and allows for the delivery of a variety of medical and pharmaceutical products to support federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $3,714.76 and a performance period ending on February 7, 2025. The contract is a Firm Fixed Price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a specialty medication, with a ceiling value of $5,629.68 and a completion date of December 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 50 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $4,924.21 and a period of performance through May 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,891.84, is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price, delivery order contract with an ultimate completion date of May 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFMGV
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a medication, with a ceiling value of $2,786.07 and a completion date of June 9, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/5/25, 9:53 AM